Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues

Treatment-resistant depression (TRD) is a common occurrence in clinical practice. Up to 30% of patients with major depression do not respond to conventional antidepressant treatment, while a significantly greater number of patients experience only partial symptom reduction. Numerous strategies may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobo, William V, Shelton, Richard C
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706569/
https://www.ncbi.nlm.nih.gov/pubmed/19590732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706569/
https://www.ncbi.nlm.nih.gov/pubmed/19590732

Ejemplares similares